Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears IMDx's MDx for Vancomycin-resistant Enterococci

NEW YORK (GenomeWeb News) – IntelligentMDx today announced it has received clearance from the US Food and Drug Administration for its molecular diagnostic test for vancomycin-resistant enterococci.

IMDx's assay detects the presence of vanA and vanB genes that have been associated with vancomycin-resistant enterococci, which are responsible for healthcare-related infections that include surgical wounds, urinary tract, and bloodstream infections.

The test runs on Abbott's fully automated m2000 platform, and is part of a broad menu of real-time PCR tests developed for use on the instrument under a multiyear distribution agreement that IMDx has with Abbott.

Because IMDX's assay is automated, laboratories are able to obtain results for up to 46 patient samples in less than three hours, and up to 94 samples in less than four hours, the Cambridge, Mass.-based firm said. The assay is performed directly on human peri-rectal swabs, rectal swabs, or stool samples.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.